Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Titel:
Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma
Auteur:
Schadendorf, Dirk Dummer, Reinhard Hauschild, Axel Robert, Caroline Hamid, Omid Daud, Adil van den Eertwegh, Alfons Cranmer, Lee O'Day, Steven Puzanov, Igor Schachter, Jacob Blank, Christian Salama, April Loquai, Carmen Mehnert, Janice M. Hille, Darcy Ebbinghaus, Scot Kang, S. Peter Zhou, Wei Ribas, Antoni